|1.||Falagiani, P: 5 articles (12/2011 - 07/2006)|
|2.||Mistrello, G: 4 articles (07/2012 - 03/2005)|
|3.||La Grutta, S: 3 articles (02/2007 - 05/2005)|
|4.||Arena, A: 3 articles (02/2007 - 05/2005)|
|5.||Gammeri, E: 3 articles (02/2007 - 05/2005)|
|6.||Leonardi, S: 2 articles (04/2015 - 02/2007)|
|7.||Zielen, Stefan: 2 articles (08/2013 - 11/2010)|
|8.||Bruno, M E: 2 articles (12/2011 - 12/2009)|
|9.||Passalacqua, G: 2 articles (07/2010 - 07/2006)|
|10.||Canonica, G W: 2 articles (07/2010 - 07/2006)|
10/01/1999 - "Conclusion Preseasonal IT with a birch pollen allergoid is clinically effective in allergic rhinitis and influences cytokine production in the nose, but does not modulate the measured responses of peripheral blood T cells."
04/01/2008 - "Eleven grass pollen-allergic patients with seasonal rhinitis were treated daily before the pollen season for 2 months with a modified allergen (monomeric allergoid) derived from a 3-grass pollen extract. "
11/17/2006 - "Twelve grass-pollen allergic patients (seven men and five women) with intermittent allergic rhinitis were treated with specific subcutaneous allergoid preparation. "
01/01/1986 - "A double-blind study comparing formaldahyde modified ragweed allergen (allergoid) and placebo in the treatment of allergic rhinitis was carried out. "
08/01/1977 - "In a pilot study, five adult patients with allergic rhinitis due to grass pollen underwent local intranasal hyposensitization with a chemically modified grass pollen extract--a so-called allergoid. "
|2.||Asthma (Bronchial Asthma)
11/01/2010 - "Adding a mite allergoid SCIT to pharmacologic treatment is an effective and safe strategy to reduce corticosteroid doses while maintaining disease control in children with mite-induced allergic asthma."
04/01/2015 - "In conclusion, both monomeric allergoid dosages of SLIT (2000 UI and 4000 UI) are a safe and efficacy option to reduce symptoms in patients with allergic asthma caused by house dust mites. "
08/01/2013 - "In 42 house dust mite (HDM) allergic children (average age: 8.6 yr) with asthma, we analysed the clinical and objective improvements of a standardised HDM allergoid. "
11/01/2010 - "The aim of this study was to investigate the efficacy of an allergen-specific immunotherapy with a high-dose hypoallergenic mite preparation (allergoid) as steroid-sparing agent in children with allergic asthma. "
12/01/2011 - "Both pre-seasonal and continuous regimen of SLIT with monomeric allergoid turned out effective and safe, suggesting that a pre-seasonal course with 5,000 AU/week for 10 weeks may represent a convenient option in patients with grass pollen allergic rhinitis with/without mild intermittent asthma. "
03/01/2010 - "The allergoid SLIT was shown to be effective and safe in Olea allergy in particular when a coseasonal regimen was used."
07/01/2012 - "Sublingual immunotherapy with monomeric carbamylated allergoid (LAIS) is an effective and well tolerated treatment of respiratory allergy. "
12/01/2011 - "Sublingual immunotherapy (SLIT) with monomeric carbamylated allergoid proved to be well tolerated, safe and effective in patients with respiratory allergy. "
11/01/2015 - "Allergoid and MPL® adsorption in different MATA-MPL allergy immunotherapy formulations is consistent and meets guideline recommendations. "
01/01/2008 - "Modified DP extract (allergoid) seems to be a good candidate for immunotherapy of patients affected by specific allergy."
|4.||Seasonal Allergic Rhinitis (Hay Fever)
11/01/1983 - "[Advantages of hyposensitization with a high dose of allergoid in pollen allergy]."
12/01/1981 - "IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever."
03/01/2005 - "Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data."
01/01/1986 - "The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever."
08/01/1992 - "A double-blind, placebo-controlled study of immunotherapy was conducted in 19 patients with grass-pollen hay fever to evaluate the efficacy and safety of a formalinized depot grass allergoid. "
|5.||Atopic Dermatitis (Atopic Eczema)
01/01/2015 - "Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis."
09/01/2007 - "Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study."
01/01/2015 - "In this study, we investigated whether allergen-specific immunotherapy (ASIT) with a monomeric allergoid obtained by succinylation of ovalbumin (sOVA) is effective in a mouse model of atopic dermatitis. "
|1.||Immunoglobulin E (IgE)
|3.||potassium cyanate (KNCO)
|10.||Aluminum Hydroxide (Algeldrate)